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Abstract The essential Nps1p/Sth1p is a catalytic subunit of
the nucleosome-remodeling complex, RSC, of Saccharomyces
cerevisiae that can alter nucleosome structure by using the en-
ergy of ATP hydrolysis. Besides the ATPase domain, Nps1p
harbors the bromodomain, of which the function(s) have not
yet been de¢ned. We have isolated a temperature-sensitive mu-
tant allele of NPS1, nps1-13, which has amino acid substitutions
within the bromodomain. This mutation perturbed the interac-
tion between the RSC components and enhanced the sensitivity
of the cells to several DNA-damaging treatments at the permis-
sive temperature. Reduced expression of NPS1 also caused
DNA damage sensitivity. These results suggest the importance
of the Nps1p bromodomain in RSC integrity and a model in
which high amounts of RSC would be required for the cells to
overcome DNA damage.
* 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
In eukaryotes, the wrapping of DNA around histone oc-
tamers to form nucleosomes blocks access of DNA bind-
ing factors and/or advancing polymerases, resulting in inhibi-
tion of transcription, replication, repair and recombination.
Recent studies have revealed that a number of special-
ized ATP-dependent nucleosome-remodeling enzymes have
evolved to overcome this inhibition [1,2]. The conservation
of this type of enzyme from yeast to humans indicates the
evolutionary importance of the nucleosome-remodeling activ-
ity. The yeast Snf/Swi and RSC are subsets of this enzyme
[3,4]. Both types are multi-subunit protein complexes and sim-
ilar in structure, sharing two identical subunits and at least
four other homologous components. RSC is approximately 10
times more abundant than Snf/Swi [4]. However, the in vivo
functions of each complex seem to be distinct. Snf/Swi is not
essential for viability, whereas loss of RSC is lethal. In addi-
tion, RSC is required for cell cycle progression through mi-
tosis [5,6], whereas Snf/Swi is not. While the involvement of
Snf/Swi in transcriptional control has been extensively studied
both genetically and biochemically, the precise role of RSC in
transcription or in other chromatin-related processes in vivo
has not yet been established.
Nps1p/Sth1p is an ATPase subunit of the RSC complex.
This protein harbors the conserved ATPase domain and the
bromodomain at the center and carboxy-terminal portions,
respectively, similar to the prototype ATPase of this family,
Snf2p/Swi2p. Previous works by Akada et al. [7] and by us
(Tsuchiya et al., unpublished) have shown that overexpression
of the C-terminal 270 amino acid portion of Nps1p containing
the bromodomain causes growth inhibition in wild-type yeast
cells, while neither that of the full-length Nps1p nor that of
the ATPase domain produced any e¡ect. To examine the
function of the C-terminal portion of Nps1p, we screened
mutations of this region and isolated three mutations that
show temperature sensitivity for growth at 38‡C. One of these
mutations alters amino acids within the bromodomain and
exhibits multiple phenotypes including DNA damage sensitiv-
ity. The bromodomain is a structural domain of 110 amino
acids, containing a central motif sequence of 60 amino acids
which has been identi¢ed in over 40 proteins implicated in
transcriptional control [8,9]. Recent studies have demon-
strated that bromodomains bind acetylated lysine residues
within the amino-terminal histone tails [10^12]. At the same
time, other studies have indicated the importance of this do-
main for protein^protein interactions in transcription-related
proteins [13^15], but the extent to which these interactions are
dependent on acetylation of some of its partners is obscure.
The role of bromodomains in ATP-dependent nucleosome-
remodeling complexes has been controversial because their
deletion has widely di¡erent consequences. Loss of the bro-
modomain of the yeast Snf2p/Swi2p causes no discernible
phenotype [16], and similar results are seen in its Drosophila
and human homologs, brahma (brm) and hbrm, respectively
[17,18]. On the other hand, the second bromodomains of
Rsc1p and Rsc2p, additional RSC subunits each containing
two tandem bromodomains, are essential [19], and partial
deletions of the bromodomain in Sth1p/Nps1p cause growth
defects at high temperature [20]. In addition, detailed func-
tions of bromodomains in these proteins, including their bind-
ing partners, are not yet understood.
Here we show that the bromodomain of Nps1p plays an
important role in the maintenance of the integrity of RSC and
the deterioration of functional RSC causes enhanced sensitiv-
ity to DNA-damaging conditions.
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2. Materials and methods
2.1. Strains, media and plasmids
All S. cerevisiae strains were derived from W303-1A (MATa ade2-1
leu2-3, 122 his3-11, 15 trp1-1 ura3-1 can 1-100) or W303-1B (MATK)
[21]. WET-1A (MATa nps1v : :HIS3/YCp50NPS1), WTH-1A (MATa
nps1-105) and WHS-r2HA-1A (MATa rsc2v : :HIS3/pRSC2.2XHA)
were as described [22,23]. WHK20-1A (MATa nps1v1247), WHK21-
1A (MATa nps1v1274) and WHK22-1A (MATa nps1v1338) were
constructed by introducing a stop codon (TAG) after C-3738, A-
3819 and C-4011 by PCR, respectively. To construct nps1v1247 and
nps1v1274, PCR reactions were carried out with primers del-U (5P-
gatttacaggcgaattctagagctcac-3P) and del1247 (5P-gggaaaaatcccatgggac-
taggattt-3P), and del-U and del1274 (5P-agcttttcaaccatgggaattcatg-
gatgggatgc-3P), respectively, and using pUC119 carrying the SacI^
NcoI fragment of NPS1 as template. To construct nps1v1338, the
PCR reaction was carried out with primers del1338 (5P-aatgaagagg-
gatcctgaattcacgtttac-3P) and pUCR (5P-tttcacacaggaaacagctatgac-3P),
and using pUC119 carrying the BamHI^ClaI fragment of NPS1 as
template. After verifying that the sequence was correct by sequencing,
each PCR product was used for interchanging with the respective
wild-type sequence on plasmid pUCNPS1 (carrying the 5.6 kb
EcoRI^ClaI fragment). Each mutant nps1 gene was excised from the
respective plasmid by EcoRI and SalI digestion and used to replace
the nps1v locus as described previously [22]. The SFH1HA allele was
constructed as follows. The 2.2 kb DNA fragment containing the
SFH1 open reading frame (ORF) was generated by PCR using prim-
ers SFHU (5P-ggaaaggatcccgttcaagtgcact-3P) and SFHR (5P-aattagtc-
gacatagaaacaagatc-3P) with genomic DNA as template. The ampli¢ed
fragment was digested with BamHI and HincII, and cloned into
pUC119 (pUCSFH1). sfh1v : :HIS3 and SFH1-3HA were constructed
by inserting the SmaI^HincII fragment containing the HIS3 gene or
the 82 bp NheI fragment containing the triad HA epitope sequence
into the unique NcoI or XbaI site within the SFH1 ORF, respectively,
on plasmid pUCSFH1. The correct direction of the HA insertion was
veri¢ed by sequencing. SFH1-3HA was excised by BamHI and SphI
digestion and inserted into the respective sites in YEp13 (YEpSFH1-
3HA). The diploid W303 (W303D) strain was transformed with the
BamHI^HincII fragment excised from pUCsfh1v : :HIS3 and then
with YEpSFH1-3HA, and Hisþ Leuþ haploid progenies were selected
after sporulation (MY40-1A). Disruption of the genomic SFH1 locus
and expression of Sfh1-Hap of MY40-1A were veri¢ed by Southern
and Western blot analyses. p314.RSC2-2XHA (RSC2-HA TRP1
CEN6) was a gift from B.R. Cairns [19]. WMY44-1A (MATa nps1-
13 sfh1v/YEpSFH1-3HA), WHK20sf-1A (MATa nps1v1247 sfh1v/
YEpSFH1-3HA) and WHK13r2HA-1A (nps1-13 rsc2v/p314.RSC2-
2XHA) were generated by crosses between WMY40-1A (MATa)
and WHK13-1B (MATK), WHK20-1A and WMY40-1B (MATK),
and WHS-r2HA-1A and WHK13-1B, respectively. A tetracycline-reg-
ulatable NPS1 allele was constructed as follows. The XhoI^PuvII frag-
ment containing tetO7 and the minimal CMV promoter, and the
SmaI^XbaI fragment containing the NPS1 ORF and terminator se-
quences were excised from pTRE2 (Clontech) and pASZ11NPS1, re-
spectively, and inserted into pRS316 (CEN6 ARS114 URA3) to con-
struct YCpTRENPS1. The tTA gene encoding a TetR-VP16 fusion
protein was excised from pTet-O¡ (Clontech) by XhoI and PvuII
digestion, and inserted between the SalI and SmaI sites within
pRS425 to construct YEptTA. YCpTRENPS1 and YEptTA, or
pASZ11NPS1 and YEptTA were introduced into WET-1A using
the plasmid shu¥ing technique [24] to construct WHK30-1A or
WHK30C-1A, respectively.
Preparation of rich (yeast extract^peptone^dextrose, YEPD) and
synthetic complete (SC) media and standard genetic methods were
as described [25].
2.2. Isolation of nps1 mutants
Introduction of mutations into the C-terminal portion of NPS1 was
carried out by PCR mutagenesis according to the method described
by Fromant et al. [26] with primers A (5P-ttacaggcccaagatagagctcac-
3P) and B (5P-ttcaatataatatcaatggccatg-3P) using genomic DNA as tem-
plate. Ampli¢ed fragments were digested with SacI and NcoI and used
to replace the same region of the wild-type gene on plasmid
pASZ11NPS1 (ARS1 CEN4 TRP1 NPS1). The resulting plasmids
were introduced into WET-1A. Approximately 6000 transformants
grown selectively for both plasmids were replicated to supplemented
SC medium containing 5-£uoroorotic acid [25] to counterselect
Fig. 1. Phenotypes of ts nps1 mutations. Wild-type (WT, W303-1A), nps1-105 (WHT-1A), nps1-13 (WHK13-1A), nps1-17 (WHK17-1A) and
nps1-19 (WHK19-1A) were grown to mid-log phase and spotted on YEPD plates containing various drugs indicated in the ¢gure. Unless other-
wise indicated, plates were incubated at 30‡C for 3 days.
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against the plasmid carrying the wild-type NPS1 gene [24]. Trans-
formants carrying only the mutagenized plasmid (3000) were screened
for lethality at 38‡C. Twenty-six mutants were temperature-sensitive
for growth. Plasmid DNA was recovered from these colonies and the
DNA sequence between SacI and NcoI was determined. All of the
mutagenized fragments contained 10^15 nucleotide changes. To deter-
mine the nucleotide changes responsible for temperature sensitivity,
these SacI^NcoI fragments were further digested with StuI, PmaCI
and PstI, and the resulting SacI^StuI, StuI^PmaCI, PmaCI^PstI and
PstI^NcoI fragments were used for fragment interchanging with the
respective wild-type sequences on pASZ11NPS1. After repeating the
screening as described above, three temperature-sensitive mutations
were identi¢ed. The nucleotide changes (and predicted amino acid
changes) of nps1-13 (WHK13-1A), nps1-17 (WHK17-1A) and nps1-
19 (WHK19-1A) were as follows: nps1-13 contained A3768T
(E1256D), T3797C (L1266S), T3806C (V1269A) and A3815T
(H1272L), nps1-17 contained A2864C (E955A), A2896G (T966A),
A2998G (K1000E) and A3002G (E1001G), and nps1-19 contained
A2906G (D969G), T2993C (I998T) and T3008C (M1003T).
2.3. Immunoprecipitation and Western blotting
Cells were grown to mid-log phase in YEPD. Preparation of whole
cell extracts and immunoprecipitation were as described [27]. To 100
Wl of the extract containing 400 Wg of protein, 2 Wg of anti-HA mouse
monoclonal antibody (clone HA11, Babco) was added. Anti-Nps1p
antibody and Western blotting were as described [5]. The amount of
each protein band detected by immunoblotting was estimated by den-
sitometry using Bio Image 60S (Bio Image).
Fig. 2. Phenotypes of nps1 bromodomain mutants. A: A schematic diagram of the Nps1 protein is shown. Regions of K-helix within the bro-
modomain were referred to the de¢nition by Jeanmougen et al. [8]. B: Wild-type (WT, W303-1A), nps1-105 (WHT-1A), nps1-13 (WHK13-1A),
nps1v1247 (WHK20-1A), nps1v1274 (WHK21-1A), and nps1v1338 (WHK22-1A) were grown to mid-log phase and spotted on YEPD plates
containing various drugs indicated in the ¢gure. Unless otherwise indicated, plates were incubated at 30‡C for 3 days.
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3. Results and discussion
3.1. A novel temperature-sensitive mutation of NPS1 maps to
the conserved bromodomain
To characterize the function of the C-terminal region of
Nps1p, temperature-sensitive (ts) mutations were generated
by PCR mutagenesis of a cloned NPS1 fragment encoding
alanine at 901 to methionine at 1298. Three independent ts
mutations were identi¢ed in a screen of about 3000 transform-
ants using the plasmid shu¥ing technique [24]. The integrated
alleles segregated 2+:23 for growth at 38‡C in crosses to a
wild-type strain. Two of the mutations (nps1-17 and nps1-19)
were recessive and the other one (nps1-13) was semi-dominant
for ts growth. All mutations caused cells to arrest in G2/M of
the cell cycle at the restrictive temperature and to be sensitive
to thiabendazole (TBZ). These phenotypes are similar to our
previously identi¢ed ATPase domain mutation, nps1-105 [22].
To further characterize the phenotypes of each mutation, we
tested the growth of these mutants on media containing caf-
feine, formamide or hydroxyurea (HU), which have been re-
ported to cause growth inhibition in mutations of other RSC
components [19], the DNA-damaging agent methyl methane-
sulfonate (MMS) and UV irradiation. As shown in Fig. 1,
nps1-13, but not other mutations, showed impaired growth
under all conditions tested at 30‡C, the permissive tempera-
ture of this mutation. Other mutations, including nps1-105,
also showed sensitivity to these reagents or UV irradiation
at the semi-permissive temperature, 35‡C (data not shown).
Ca¡eine inhibits the kinase activity of ATM (ataxia telangiec-
tasia mutated) and ATR (ataxia telangiectasia related) which
encode protein kinases involved in the DNA damage check-
point pathway [28,29], and HU inhibits ribonucleotide reduc-
tase to block DNA replication. Replication block frequently
causes a break of stalled forks, a process called replication
fork collapse [30]. Therefore, nps1 mutations, especially
nps1-13, were thought to enhance sensitivity of the cells to
DNA damage. The nps1-13 mutation alters amino acids in
the conserved bromodomain that extends from amino acids
1253 to 1359. The bromodomain consists of four K-helices
(termed helices Z, A, B and C from the amino-terminal
side, Fig. 2A) and long intervening loops between helices Z
and A (ZA loop), and helices B and C (BC loop) [8,10]. The
amino acid substitutions of nps1-13 are E1261D, L1266S,
V1269A and H1272L locating within and near helix Z of
the bromodomain. The other two mutations identi¢ed in
this study alter amino acids between amino acids 955 and
1003, the region £anking the ATPase domain.
Du et al. [20] reported that deletions of amino acids 1274^
1359 (corresponding to the region from helix A of the bro-
modomain to the C-terminus) and 1338^1359 (corresponding
to helix C of the bromodomain to the C-terminus) show weak
and strong temperature sensitivity, respectively. Because phe-
notypes of complete deletion of the bromodomain have not
yet been characterized, we constructed nps1v1247, which lacks
all of the bromodomain, in addition to two previously de-
scribed deletion alleles, sth1/nps1v1274 and sth1/nps1v1238,
and accessed their growth under various conditions. As de-
scribed by Du et al., nps1v1274 and nps1v1238 exhibited weak
and strong temperature sensitivity, respectively (Fig. 2B).
However, nps1v1247 exhibited no discernible phenotype com-
pared to the wild-type. Interestingly, among these bromodo-
main deletion mutations, only nps1v1238 exhibited sensitivity
to TBZ and DNA-damaging conditions similar to nps1-13.
3.2. Bromodomain mutations of NPS1 perturb interaction
between RSC components
A number of studies have shown the interaction between
bromodomains and peptides derived from histone N-terminal
tails, in a manner dependent on acetylation of lysine residues
Fig. 3. nps1-13 mutation perturbs interaction between the RSC com-
ponents. Whole cell extracts were prepared from WMY40-1A
[NPS1 (WT) sfh1v/YEpSFH1HA], WMY44-1A (nps1-13 sfh1v/
YEpSFH1HA), WHK20sf-1A (nps1v1247 sfh1v/YEpSFH1HA),
WHS-r2HA-1A (rsc2v/pRSC2.2XHA) and WHK13r2HA-1A (nps1-
13 rsc2v/pRSC2.2XHA) and utilized for immunoprecipitation ex-
periments using anti-HA antibody. The immunoprecipitation pellet
derived from 400 Wg of whole cell extract was divided into two por-
tions, separated through SDS^7.5% acrylamide gels and immuno-
blotted with anti-Nps1p or anti-HA antibody. In ‘input’ lanes, 100
Wg of a whole cell extract from each strain was loaded. The num-
bers under each panel indicate the fold change of immunoprecipi-
tated Nps1p versus Sfh1HAp or Rsc2Hap estimated by densitome-
try ( V S.D., n=3). The values of the wild-type cells are referred
to as 1. A: WT: WMY40-1A; nps1-13 : WMY44-1A; nps1v1247 :
WHK20s-1A. B: WT: WHS-r2HA-1A; nps1-13 : WHK13r2HA-1A.
C
Fig. 4. Phenotypes of the strain that expresses NPS1 under the control of a TC-regulatable promoter. A: Nps1p levels in WHK30C-1A
(NPS1, nps1v/pASZ11NPS1 YEptTE) and WHK30-1A (tetNPS1, nps1v/YCpTRENPS1 YEptTE) are shown. Whole cell extracts were prepared
from cells grown for 12 h in YEPD medium containing various amounts of TC indicated in the ¢gure. The numbers under each lane indicate
fold change of Nps1p versus Cdc28p estimated by densitometry ( VS.D., n=3). The values of the WHK30C-1A cells in the absence of TC are
referred to as 1. B: WHK30C-1A, WHK30-1A and WHK13-1A grown to mid-log phase were spotted on YEPD plates containing various
drugs indicated in the ¢gure. Unless otherwise indicated, plates were incubated at 30‡C for 3 days. C: E¡ect of HU (200 mM, closed circles
with solid line), MMS (0.005%, closed diamonds with ¢ne dotted line) and UV irradiation (20 J/m2, closed rectangles with dotted line) on the
viability of WHK30-1A. The cells (300^3000) were plated on YEPD plates containing various amount TC, TC and HU or MMS indicated in
the ¢gure. After 3 days incubation at 30‡C, colonies that had appeared on each plate were counted. The viability (colony number/total cell
number) of WHK30C-1A grown in the absence of TC is referred to as 100. Open circles with solid line indicate the viability of WHK30-1A on
plates containing only TC. An average of three independent experiments with ¢ve plates per drug concentration is plotted.
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within the peptide [10^12]. Acetyl-lysine binding occurs
through residues in the ZA loop and BC loop. nps1-17 con-
tained an additional amino acid substitution within the bro-
modomain, Y1290H, when it was originally isolated. This res-
idue is absolutely conserved in bromodomains and has been
demonstrated to be implicated in acetyl-lysine interaction [10^
12]. However, the growth of the Y1290H mutation alone was
indistinguishable from the wild-type (data not shown).
Recent studies suggest the implication of bromodomains in
the interaction with proteins other than histones [13^15]. We
thought it was possible that the bromodomain of Nps1p con-
tributes to the interaction with other components of the RSC
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complex. Because Sfh1p interacts directly with Nps1p [6], we
generated strains expressing HA-tagged Sfh1p and performed
coimmunoprecipitation experiments. Although anti-HA anti-
bodies could coimmunoprecipitate Nps1p in all the strains
tested, the amount of Nps1p in the precipitates from
nps1v1247 and nps1-13 cell lysates decreased to 69% and
18% of that from the wild-type cells, respectively (Fig. 3A).
We also performed coimmunoprecipitation experiment using
HA-tagged Rsc2p, a component of RSC [19], and obtained
similar results (Fig. 3B). These results indicated that the bro-
modomain of Nps1p plays an important role in the interac-
tion with other RSC components. The observation that com-
plete deletion of the bromodomain (nps1v1247) caused
moderate disturbance of Nps1p^Sfh1p interaction while the
nps1-13 mutation, which alters amino acids in helix Z, caused
severe disturbance in Nps1p^Sfh1p interaction suggests that
the bromodomain of Nps1p may not be a direct binding site
for other RSC components. nps1v1338, which lacks the bro-
modomain helix C, and nps1-13 exhibited similar phenotypes.
Possibly these two mutations cause alterations of the ternary
structure of the bromodomain and this may also result in the
alteration of Nps1p total structure. Although the domain of
Nps1p involved in the interaction with Sfh1p or other RSC
components remains to be determined, we speculate that the
bromodomain of Nps1p assists the binding by supporting the
proper structure of the binding site. Whether the interaction
between Nps1p and Rsc2p is direct or not is unclear [19]. A
recent study on Snf5p, a component of the Snf/Swi complex
and a prototype paralog of Sfh1p, indicated the importance of
this protein to the integrity of the complex [31]. Therefore, it
is possible that the reduced interaction between Nps1p and
Sfh1p results in the release of Rsc2p from the complex.
3.3. Reduced expression of Nps1p enhances sensitivity to DNA
damage
The above observations that the nps1v1247 mutation,
which caused moderate reduction of the interaction with
Sfh1p, showed no discernible growth defect, while the nps1-
13 mutation, which caused severe disturbance in the interac-
tion, showed multiple growth defects suggested that an abun-
dance of Nps1p/RSC is required for the tolerance to TBZ or
DNA-damaging agents, or for the growth at high tempera-
tures. To test this possibility, we constructed a strain that
expresses NPS1 under the control of a tetracycline (TC)-reg-
ulatable promoter (tetNPS1, nps1v/YCpTRENPS1 YEptTE).
We ¢rst determined that Nps1p levels responded to the TC
concentration. In the absence of TC, the level of Nps1p in
tetNPS1 was about 76% of that in the NPS1 wild-type control
strain (WHK30C-1A, nps1v/pASZ11NPS1 YEptTE, referred
to as wild-type hereafter), rapidly decreased to 35% by the
addition of 1 Wg/ml of TC and then gradually decreased to
12% by the addition of 50 Wg/ml TC (Fig. 4A). The addition
of 100 Wg/ml TC caused severe growth delay with the accu-
mulation of G2/M cells in tetNPS1 (data not shown). Never-
theless, the addition of up to 50 Wg/ml TC did not a¡ect the
viability of both the tetNPS1 and the wild-type strains (Fig.
4C, data of the control strain are not shown).
Next, we examined the e¡ect of TBZ, HU, MMS, UV ir-
radiation and high temperature (37‡C) on the growth of
tetNPS1. The addition of 120 Wg/ml TBZ to the medium or
incubation at 37‡C did not a¡ect the growth of tetNPS1 re-
gardless of the presence of TC (Fig. 4B). On the other hand,
the growth of tetNPS1 was severely impaired by 200 mM HU,
0.005% MMS or 20 J/m2 UV irradiation when 10 Wg/ml TC
was present. As shown in Fig. 4C, viability of the tetNPS1
cells rapidly declined by the addition of HU or MMS, or by
UV irradiation in concert with the increase of the TC concen-
tration present in the medium; viability of the cells declined to
25% (HU) or 50% (MMS or UV) in the presence of 1 Wg/ml
TC and to less than 1% (HU) or about 6% (MMS or UV) in
the presence of 10 Wg/ml TC. Under the same conditions, the
viability of the wild-type strain remained unchanged (data not
shown). The nps1-13 mutation, but not tetNPS1, showed TBZ
and temperature sensitivity indicating that the aberrant struc-
ture of the bromodomain in nps1-13 may a¡ect not only the
interaction with other RSC components but also the catalytic
activity of Nps1p. Overall, the decrease of the functional RSC
in both tetNPS1 and nps1-13 enhanced the sensitivity to
DNA-damaging conditions, suggesting that an abundance of
RSC is important for the maintenance of viability under
DNA-damaging conditions. Taken together with the fact
that nps1 mutations other than nps1-13 also enhance sensitiv-
ity to DNA-damaging conditions at the semi-permissive tem-
perature, RSC is likely to be involved in the DNA damage
response pathway. We observed the cell cycle arrest occurred
in nps1-13 when treated with HU or MMS, suggesting that
the mutation may not a¡ect the DNA damage checkpoint
pathway (Koyama et al., unpublished). DNA damage is
known to arise spontaneously during the proliferation pro-
cess. Abundant RSC could facilitate the rapid response of
the cells to overcome DNA damage by transcriptional activa-
tion or repression, and/or assisting the access of repair en-
zymes to damage sites. Further analysis on the functions of
RSC in DNA damage response is in progress in our labora-
tory.
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